Drug intelligence / Profile preview

alpha-amylase + pepsin

Development stage
Unknown
Lead developer
Charan Laboratories
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Digihep is a branded generic digestive enzyme formulation developed and marketed by Charan Laboratories. It is typically formulated as a syrup containing a combination of fungal diastase (a form of alpha-amylase) and pepsin. Fungal diastase, often derived from *Aspergillus oryzae*, is an enzyme that catalyzes the hydrolysis of complex carbohydrates (starch) into simpler sugars like maltose, thereby assisting in carbohydrate digestion. Pepsin is a proteolytic enzyme that breaks down dietary proteins into smaller peptides. This combination is indicated for the treatment of various digestive disorders, including indigestion, dyspepsia, flatulence, and loss of appetite, by supplementing the body's natural digestive enzymes. While the brand name 'Digihep' suggests both digestive and hepatic support, the primary formulation in Charan Laboratories' portfolio is focused on these digestive enzymes.

Brand names
Digihep
Other names
fungal diastase + pepsinDigihep syrup

Beyond the preview

Go deeper on alpha-amylase + pepsin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-amylase + pepsin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call